CMS Finalizes Rule to Eliminate Lag Between FDA Approval of Breakthrough Devices and Medicare Coverage
- January 15, 2021
Breakthrough medical devices will be covered by Medicare on the same day they receive Food and Drug Administration (FDA) market authorization under a final rule the Centers for Medicare & Medicaid Services (CMS) published January 14 (85 Fed. Reg. ).
You must be logged in to access this content.